Interstitial Lung Disease
299
69
77
109
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
25 trials with published results (8%)
Research Maturity
109 completed trials (36% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.4%
16 terminated out of 299 trials
87.2%
+0.7% vs benchmark
9%
26 trials in Phase 3/4
23%
25 of 109 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 109 completed trials
Clinical Trials (299)
WTC Chest CT Imaging Archive
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
Usability and Acceptability Study of the P-STEP Mobile Application
Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
Aerobic Exercise in Patients With Pulmonary Hypertension
Correlation Between PaO2/FiO2 and Lung Ultrasound Score in the Intensive Care Unit
dEtection of rheumAtoid aRthritis - Interstitial Lung dIseasE by Thoracic ultRasound
The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Feasibility of Semaglutide in Advanced Lung Disease
Early Recognition of Progressive Lung Fibrosis in Systemic Rheumatic Diseases
Collagen-targeted PET Imaging for Early Interstitial Lung Disease